Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB for Inflammatory bowel disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where RISANKIZUMAB was used for Inflammatory bowel disease.

Most Reported Side Effects for RISANKIZUMAB

Side Effect Reports % Deaths Hosp.
Product storage error 396 15.0% 0 3
Drug ineffective 206 7.8% 2 40
Psoriasis 138 5.2% 2 25
Crohn's disease 103 3.9% 1 23
Arthralgia 100 3.8% 2 13
Off label use 100 3.8% 1 9
Product temperature excursion issue 88 3.3% 0 1
Diarrhoea 72 2.7% 1 7
Fatigue 70 2.7% 0 4
Rash 64 2.4% 1 10
Pruritus 61 2.3% 0 12
Headache 58 2.2% 2 13
Therapeutic product effect decreased 56 2.1% 0 11
Abdominal pain 50 1.9% 0 28
Urticaria 49 1.9% 0 1

Other Indications for RISANKIZUMAB

Psoriasis (1,051) Crohn's disease (863) Product used for unknown indication (340) Colitis ulcerative (162) Psoriatic arthropathy (161) Generalised pustular psoriasis (18) Pustular psoriasis (14) Maternal exposure timing unspecified (8) Rheumatoid arthritis (7) Skin disorder (7)

Other Drugs Used for Inflammatory bowel disease

INFLIXIMAB (3,697) VEDOLIZUMAB (1,342) ADALIMUMAB (820) USTEKINUMAB (470) AZATHIOPRINE (304) MESALAMINE (301) METHOTREXATE (160) GOLIMUMAB (126) PREDNISOLONE (121) UPADACITINIB (116)

Related Pages

RISANKIZUMAB Full Profile All Inflammatory bowel disease Drugs RISANKIZUMAB Demographics RISANKIZUMAB Timeline